COVID-19 and persons with substance use disorders: Inequities and mitigation strategies

Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse
Osnat C MelamedBenoit H Mulsant

Abstract

The COVID-19 pandemic disproportionately disrupts the daily lives of marginalized populations. Persons with substance use disorders are a particularly vulnerable population because of their unique social and health care needs. They face significant harm from both the pandemic itself and its social and economic consequences, including marginalization in health care and social systems. Hence, we discuss: (1) why persons with substance use disorders are at increased risk for infection with COVID-19 and a severe illness course; (2) anticipated adverse consequences of COVID-19 in persons with substance use disorders; (3) challenges to health care delivery and substance use treatment programs during and after the COVID-19 pandemic; and (4) the potential impact on clinical research in substance use disorders. We offer recommendations for clinical, public health, and social policies to mitigate these challenges and to prevent negative outcomes.

References

Oct 19, 2005·Public Health Nursing·Maureen A CavaRouleen Wignall
Mar 7, 2006·General Hospital Psychiatry·Benjamin G Druss, Silke A von Esenwein
May 16, 2007·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Antoinette M LeeSiew E Chua
Jun 5, 2007·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·Mustafa al'AbsiStephan Bongard
Jan 17, 2008·The American Journal of Psychiatry·Lissa DutraMichael W Otto
Aug 10, 2012·Primary Care Respiratory Journal : Journal of the General Practice Airways Group·Frances PalmerJohn Haughney
May 2, 2013·Pharmacology & Therapeutics·Jennifer M Loftis, Marilyn Huckans
May 17, 2014·Respirology : Official Journal of the Asian Pacific Society of Respirology·Peter GatesJan Copeland
May 29, 2015·Chest·Paul P WalkerPeter M A Calverley
Sep 24, 2015·Addiction·Joseph GuydishKevin Delucchi
Jan 28, 2016·The New England Journal of Medicine·Nora D VolkowA Thomas McLellan
May 12, 2017·Substance Abuse and Rehabilitation·Udo Bonnet, Ulrich W Preuss
May 28, 2017·Social Psychiatry and Psychiatric Epidemiology·Kenneth S KendlerJan Sundquist
Apr 16, 2019·Addiction Science & Clinical Practice·Paul J JoudreyAaron D Fox
Mar 12, 2020·The New England Journal of Medicine·Judd E Hollander, Brendan G Carr
Mar 15, 2020·The Lancet. Public Health·Jack Tsai, Michal Wilson
Mar 20, 2020·BMJ : British Medical Journal·Janice Hopkins TanneAcer Garcia Rada
Mar 21, 2020·European Journal of Internal Medicine·Giuseppe Lippi, Brandon Michael Henry
Mar 23, 2020·The Lancet. Psychiatry·Hao YaoYi-Feng Xu
Mar 24, 2020·The New England Journal of Medicine·Ezekiel J EmanuelJames P Phillips
Mar 25, 2020·Tobacco Induced Diseases·Constantine I Vardavas, Katerina Nikitara
Mar 27, 2020·JAMA : the Journal of the American Medical Association·Mary M McDermott, Anne B Newman
Apr 3, 2020·The New England Journal of Medicine·Matthew J AkiyamaJosiah D Rich
Apr 22, 2020·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Traci C GreenDeborah S Finnell
Apr 29, 2020·Schizophrenia Bulletin·Nicole KozloffAristotle N Voineskos

❮ Previous
Next ❯

Citations

Nov 5, 2020·Prehospital Emergency Care : Official Journal of the National Association of EMS Physicians and the National Association of State EMS Directors·Scott G WeinerScott A Goldberg
Feb 26, 2021·Addiction Science & Clinical Practice·Miriam T H HarrisZoe M Weinstein
Apr 29, 2021·The American Journal of Drug and Alcohol Abuse·Barbara Andraka-ChristouBradley D Stein
May 19, 2021·Current Opinion in Psychiatry·Kripa BalaramDavid C Kaelber
May 22, 2021·Current Opinion in Psychiatry·Pratima Murthy, Venkata Lakshmi Narasimha
Jun 3, 2021·International Journal of Environmental Research and Public Health·Jacques GaumeFrank Zobel
Mar 7, 2021·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Javier A TamargoMarianna K Baum
Jun 30, 2021·Journal of Substance Abuse Treatment·Chunqing LinYih-Ing Hser
Sep 25, 2021·Translational Psychiatry·Qiuping HuangHongxian Shen

❮ Previous
Next ❯

Software Mentioned

Quitlines

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.